BUSINESSAug 3 · 04:35 UTCFINANCIAL TIMES WORLD

FirstFT: AstraZeneca and Bristol Myers Squibb discuss $400bn tie-up

AstraZeneca and Bristol Myers Squibb are discussing a potential $400 billion merger. The article also references a migrant crossing in Ceuta and UEFA's response to a failed FIFA plan.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

AstraZenecaorganizationBristol Myers SquibborganizationCeutaplaceUEFAorganizationFIFAorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

BUSINESSAug 2 · 20:12 UTC
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
BUSINESSAug 2 · 21:27 UTC
AstraZeneca said to have explored Bristol Myers merger
BUSINESSAug 2 · 20:13 UTC
AstraZeneca Said to Have Explored Bristol Myers Merger
BUSINESSAug 2 · 21:40 UTC
AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
BUSINESSMay 12 · 07:48 UTC
STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs
HEALTHJun 9 · 13:39 UTC
STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more